ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R.
Cheli Y, et al. Among authors: bertolotto c.
Mol Cancer. 2021 Jan 7;20(1):12. doi: 10.1186/s12943-020-01306-2.
Mol Cancer. 2021.
PMID: 33413419
Free PMC article.